YS

Yogesh Shantaram Ugale

Active Director Director DIN 07112249
DIN 07112249 First appointment Apr 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Yogesh Shantaram Ugale

Data last updated:

Yogesh Shantaram Ugale is a Director at Pharmac Drugs Private Limited (since 2015). The company operates in Trading. Pharmac Drugs Private Limited reported revenue of ₹1.50 Cr (FY 2025).

DIN 07112249
Primary Designation Director
Industry Trading
First Appointment 01 Apr 2015
Oldest Company Age 11 yrs
Largest company Pharmac Drugs Private Limited · ₹1.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmac Drugs Private Limited U51909PN2015PTC154577
Director01 Apr 20152015₹1.50 Cr (FY 2025)Active

Board colleagues of Yogesh Shantaram Ugale

Directorship timeline

Open interactive timeline →
Pharmac Drugs Private Limited
Premium access

Shareholding and investment profile for Yogesh Shantaram Ugale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Shantaram Ugale

Yogesh Shantaram Ugale currently holds 1 directorship: Pharmac Drugs Private Limited (Director, since 01 Apr 2015, revenue ₹1.50 Cr (FY 2025)).

Yogesh Shantaram Ugale was first appointed on 01 Apr 2015 as Director at Pharmac Drugs Private Limited.

The current boards of Yogesh Shantaram Ugale's companies include Jayshri Prashant Devrat (Pharmac Drugs Private Limited), Jyoti Nilesh Bankar (Pharmac Drugs Private Limited), Vijay Bapu Lokhande (Pharmac Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available